Antares Vision Group introduced LDA, an in-line micro-leakage inspection system for aerosol products, featuring advanced spectroscopic sensors that detect microscopic gas leaks during production.
The technology was presented for launch at Cosmopack Bologna (March 26–28, 2026) and was submitted as a candidate for the 2026 Cosmopack Awards in the Innovation Technology category. LDA was designed to provide 100% line control without stopping the production flow, aiming to reduce waste while maintaining continuous inspection.
The system integrates with existing traceability and quality-control frameworks from Antares Vision Group, supporting regulatory compliance and supply-chain security. For brands and manufacturers, LDA promised tighter product safety and fewer quality escapes, helping cosmetics and aerosol makers meet stricter standards and limit recalls and parallel-market risks.
In-Line Micro-Leakage Sensors
Antares Vision Group Introduced LDA In-Line Micro Leakage Inspection
Trend Themes
-
In-line Micro-leakage Inspection — Real-time detection of microscopic gas leaks during production enables near-zero defect throughput that could redefine quality assurance thresholds for packaged goods.
-
Spectroscopic Sensor Integration — Advanced spectroscopy embedded into production lines provides a new layer of molecular-level verification that can replace slower, sample-based laboratory testing.
-
Continuous 100% Line Control — Uninterrupted full-line inspection promises to minimize recalls and waste by ensuring every unit meets standards without halting manufacturing flow.
Industry Implications
-
Cosmetics Manufacturing — Tighter inline leak detection can significantly reduce product contamination risks and brand liability in high-volume beauty product lines.
-
Aerosol Product Production — Micro-leak sensors offer a pathway to certify pressurized containers more reliably, improving safety compliance and shelf-life assurance for aerosol goods.
-
Pharmaceutical Packaging — Integration with traceability systems could elevate sterile barrier verification and regulatory documentation for parenteral and inhalable drug packaging.